Articles 7 Questions: Digital healthcare & technology pharmaphorum spoke to digital health strategist and influencer Denise Silber about how and where technology is, and will be, affecting the healthcare environment.
News ADA: AZ reveals oral GLP-1 data in obesity, diabetes AstraZeneca prepares to move its oral GLP-1 elecoglipron into phase 3 for obesity and diabetes, after reporting encouraging phase 2b data at ADA.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.